IFNA1 and systemic lupus erythematosus: IFN signature is a key marker in the pathogenesis of several SRD, and it has been associated with PE presentation in SLE and primary APS patients, however, there is no data concerning IFN immunohistochemical expression in the placenta of patients with SRD [23, 28, 41].